Max Robotics — Global Service Robot Directory + US Certification

About

Masahiro Asari is a pioneering colorectal surgeon at the forefront of robotic surgery innovation in Japan. His research focuses on the clinical application and refinement of next-generation robotic platforms—specifically the Senhance Surgical System—for minimally invasive colorectal cancer treatment. Asari’s major contributions include performing Japan’s first ileocecal resection using the Senhance system (17 citations), demonstrating the feasibility of D3 lymph node dissection for right-sided transverse colon cancer with this platform (8 citations), and pioneering the first single-incision plus one-port transverse colon resection using the Senhance Digital Laparoscopy System (5 citations). These case reports collectively establish critical benchmarks for oncological safety, reduced port invasiveness, and technical reproducibility in robotic colorectal surgery. By systematically documenting these early experiences, Asari has helped validate the Senhance system as a viable alternative to established robotic platforms, expanding surgical options for patients. His work is particularly notable for bridging the gap between emerging robotic technology and rigorous oncologic principles, ensuring that innovation does not compromise cancer treatment outcomes. Asari’s contributions are shaping the future of minimally invasive colorectal surgery in Japan and beyond.